Dr. Masterman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Prothena Bioscienes
1800 Sierra Point Parkway
Brisbane, CA 94005Phone+1 805-439-7574
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1990 - 1993
University of WashingtonInternship, Internal Medicine, 1989 - 1990- University of Washington School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1991 - 2015
Publications & Presentations
PubMed
- 1122 citationsOcrelizumab versus Placebo in Primary Progressive Multiple SclerosisXavier Montalban, Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar-Or
The New England Journal of Medicine. 2017-01-19 - 1139 citationsOcrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.Stephen L. Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans Peter Hartung
The New England Journal of Medicine. 2017-01-19 - 317 citationsOral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study.John M. Ringman, Sally A. Frautschy, Edmond Teng, Aynun N. Begum, Jenny Bardens
Alzheimer's Research & Therapy. 2012-10-29
Grant Support
- Core--ClinincalNational Institute On Aging2004–2008
- Trial Of Metrifonate For Treatment Of Probable Alzheimers DiseaseNational Center For Research Resources1999–2001
- Donepezil Hydrochloride In Patients W/ DementiaNational Center For Research Resources1999–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
